Meng-Ru Shen

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

N/A

0Author DataRank · unranked

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer”.

Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer

Scientific Reports(2019)10.1038/s41598-019-40571-0

N/A

0.442DataRank · unranked

18 citations

Yu-Min Yeh, Pei-Ying Wu, Keng-Fu Hsu, Jang-Yang Chang, Meng-Ru Shen +1 more

Germline MLH1 and MSH6 mutations from two Lynch syndrome families identified in a patient with early-onset of endometrial cancer: A case report

Gynecologic Oncology Reports(2024)10.1016/j.gore.2024.101381

N/A

0.104DataRank · unranked

1 citations

Peng-Chan Lin, Pei-Ying Wu, Nai-Syuan Chen, Meng-Ru Shen, Yu-Min Yeh +2 more